世界の創薬インフォマティクス市場2021-2028:モード別(社内、アウトソーシング)、ワークフロー別(検出、開発)、サービス別(シーケンス分析プラットフォーム、ドッキング)

◆英語タイトル:Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Mode (In-house, Outsourced), By Workflow (Discovery, Development), By Services (Sequence Analysis Platforms, Docking), And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MA011
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の創薬インフォマティクス市場規模が年平均11.3%成長し、2028年までに56.3億ドルに達すると予測しています。本調査レポートでは、創薬インフォマティクスの世界市場について広く調査・分析し、調査手法・範囲、エグゼクティブサマリー、産業動向、ワークフロー別(検出、開発)分析、モード別(アウトソーシング、組織内)分析、サービス別(シーケンス分析プラットフォーム、分子モデリング、ドッキング、臨床試験データ管理、その他)分析、地域別分析、競争状況など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・産業動向
・創薬インフォマティクスの世界市場規模:ワークフロー別(検出、開発)
・創薬インフォマティクスの世界市場規模:モード別(アウトソーシング、組織内)
・創薬インフォマティクスの世界市場規模:サービス別(シーケンス分析プラットフォーム、分子モデリング、ドッキング、臨床試験データ管理、その他)
・創薬インフォマティクスの世界市場規模:地域別
・競争状況
【レポートの概要】

Drug Discovery Informatics Market Growth & Trends

The global drug discovery informatics market size is expected to reach USD 5.63 billion by 2028 registering a CAGR of 11.3% over the forecast period, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use Artificial Intelligence (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent Covid-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid Covid-19 drug discovery. Hence, the need to facilitate drug development for Covid-19 is expected to propel the industry expansion over the coming years.

Drug Discovery Informatics Market Report Highlights

• The discovery workflow segment accounted for the largest share of 59.19% in 2020 owing to the increased focus of pharmaceutical companies on the development of novel drug candidates

• The development workflow segment is expected to register the fastest CAGR from 2021 to 2028 owing to a rise in the number of drug candidates in the clinical development phase

• The outsourced mode segment led the market in 2020; however, the in-house mode segment will generate the maximum revenue by 2028 growing at the fastest CAGR over the forecast period owing to high demand for such platforms & services across Asia Pacific countries

• Led by the U.S., North America led the global market in 2020 due to the presence of key market players and established R&D infrastructure in the country

• Key industry participants focus on strategic acquisitions to sustain the market competition

• For instance, in January 2021, Selvita acquired Fidelta to enhance its integrated drug discovery service offerings and expand business in the Europe market

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information procurement
1.2 List of Data Sources
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
Chapter 2 Executive Summary
Chapter 3 Drug Discovery Informatics Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects, 2017 – 2028 (USD Million)
3.3 Drug discovery informatics market dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing adoption of in-silico modeling tools
3.3.1.2 Advancements in high-performance computing and web services
3.3.1.3 Growing volume of drug discovery data
3.3.1.4 Growth in demand for novel drug moieties
3.3.2 Market restraint analysis
3.3.2.1 Downward pricing pressure and outsourcing for services
3.3.2.2 Intellectual property protection and public policy issues
3.3.2.3 Presence of open-source software packages for drug discovery
3.4 Penetration & Growth Prospect Mapping for Work-flow, 2020 (USD Million)
3.5 Industry analysis – Porter’s
3.6 Drug discovery informatics PESTEL Analysis
3.7 COVID-19 Impact Analysis: Drug Discovery Informatics Market
Chapter 4 Drug Discovery Informatics Workflow Outlook
4.1 Global drug discovery informatics revenue share, by workflow, 2020 & 2028
4.2 Discovery informatics
4.2.1 Discovery informatics market, 2017 – 2028 (USD Million)
4.2.2 Identification, validation, & assay development informatics
4.2.2.1 Identification, validation & assay development informatics market, 2017 – 2028 (USD Million)
4.2.3 Lead generation informatics
4.2.3.1 Lead generation informatics market, 2017 – 2028 (USD Million)
4.3 Development informatics
4.3.1 Development informatics market, 2017 – 2028 (USD Million)
4.3.2 Lead optimization
4.3.2.1 Lead optimization market, 2017 – 2028 (USD Million)
4.3.3 FHD preparation
4.3.3.1 FHD preparation market, 2017 – 2028 (USD Million)
4.3.4 Phase IA informatics
4.3.4.1 Phase IA informatics market, 2017 – 2028 (USD Million)
4.3.5 Phase IB/2 informatics
4.3.5.1 Phase IB/2 informatics market, 2017 – 2028 (USD Million)
Chapter 5 Drug Discovery Informatics Mode Outlook
5.1 Global drug discovery informatics revenue share, by mode, 2020 & 2028
5.2 Outsourced Informatics
5.2.1 Outsourced informatics market, 2017 – 2028 (USD Million)
5.3 In-house informatics
5.3.1 In-house informatics market, 2017 – 2028 (USD Million)
Chapter 6 Drug Discovery Informatics Service Outlook
6.1 Global drug discovery informatics revenue share, by service, 2020 & 2028
6.2 Sequence analysis platforms
6.2.1 Sequence analysis platforms market, 2017 – 2028 (USD Million)
6.3 Molecular Modelling
6.3.1 Molecular modelling market, 2017 – 2028 (USD Million)
6.4 Docking
6.4.1 Docking market, 2017 – 2028 (USD Million)
6.5 Clinical trial data management
6.5.1 Clinical trial data management market, 2017 – 2028 (USD Million)
6.6 Other services
6.6.1 Other services market, 2017 – 2028 (USD Million)
Chapter 7 Drug Discovery Informatics Regional Outlook
7.1 Global drug discovery informatics revenue share, by region, 2020 & 2028
7.2 North America
7.2.1 North America drug discovery informatics market, 2017 – 2028 (USD Million)
7.2.2 The U.S
7.2.2.1 The U.S. drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.2.2.2 The U.S. drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.2.2.3 The U.S. drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Canada drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.2.3.2 Canada drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.2.3.3 Canada drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.3 Europe
7.3.1 Europe drug discovery informatics market, 2017 – 2028 (USD Million)
7.3.2 Germany
7.3.2.1 Germany drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.3.2.2 Germany drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.3.2.3 Germany drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.3.3 The U.K.
7.3.3.1 The U.K. drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.3.3.2 The U.K. drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.3.3.3 The U.K. drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.3.4 France
7.3.4.1 France drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.3.4.2 France drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.3.4.3 France drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.3.5 Italy
7.3.5.1 Italy drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.3.5.2 Italy drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.3.5.3 Italy drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.3.6 Spain
7.3.6.1 Spain drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.3.6.2 Spain drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.3.6.3 Spain drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific drug discovery informatics market, 2017 – 2028 (USD Million)
7.4.2 Japan
7.4.2.1 Japan drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.4.2.2 Japan drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.4.2.3 Japan drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.4.3 China
7.4.3.1 China drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.4.3.2 China drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.4.3.3 China drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.4.4 India
7.4.4.1 India drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.4.4.2 India drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.4.4.3 India drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.5 Latin America
7.5.1 Latin America drug discovery informatics market, 2017 – 2028 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.5.2.2 Brazil drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.5.2.3 Brazil drug discovery informatics market, by service, 2017 – 2028 (USD Million)
7.6 Middle East & Africa
7.6.1 Middle East & Africa drug discovery informatics market, 2017 – 2028 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa drug discovery informatics market, by workflow, 2017 – 2028 (USD Million)
7.6.2.2 South Africa drug discovery informatics market, by mode, 2017 – 2028 (USD Million)
7.6.2.3 South Africa drug discovery informatics market, by service, 2017 – 2028 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 PerkinElmer, Inc.
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Thermo Fisher Scientific, Inc.
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Certara, L.P.
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 NOVO INFORMATICS PVT. LTD
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.5 Collaborative Drug Discovery Inc.
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Jubilant Life Sciences Limited
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product Benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Selvita
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Charles River Laboratories International, Inc.
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 ChemBridge Corporation
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Albany Molecular Research Inc. (AMRI)
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
8.1.11 GVK Biosciences Private Limited,
8.1.11.1 Company overview
8.1.11.2 Financial performance
8.1.11.3 Product benchmarking
8.1.11.4 Strategic initiatives
8.1.12 Infosys Ltd.
8.1.12.1 Company overview
8.1.12.2 Financial performance
8.1.12.3 Product benchmarking
8.1.12.4 Strategic initiatives
8.1.13 Accenture.
8.1.13.1 Company overview
8.1.13.2 Financial performance
8.1.13.3 Product benchmarking
8.1.13.4 Strategic initiatives
8.1.14 Oracle.
8.1.14.1 Company overview
8.1.14.2 Financial performance
8.1.14.3 Product benchmarking
8.1.14.4 Strategic initiatives
8.1.15 Agilent Technologies, Inc.
8.1.15.1 Company overview
8.1.15.2 Financial performance
8.1.15.3 Product benchmarking
8.1.15.4 Strategic initiatives

List of Tables

TABLE 1 Drug Discovery Informatics - Industry Snapshot & Key Buying Criteria, 2017 - 2028
TABLE 2 Drug discovery informatics market, by work flow, 2017 - 2028 (USD Million)
TABLE 3 Drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 4 Drug discovery informatics market, by services, 2017 - 2028 (USD Million)
TABLE 5 Drug discovery informatics market, by region, 2017 - 2028 (USD Million)
TABLE 6 Drug discovery informatics key market driver analysis
TABLE 7 Drug discovery informatics key market restraint analysis
TABLE 8 North America drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 9 North America discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 10 North America development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 11 North America drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 12 North America drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 13 The U.S. drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 14 The U.S. discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 15 The U.S. development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 16 The U.S. drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 17 The U.S. drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 18 Canada drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 19 Canada discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 20 Canada development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 21 Canada drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 22 Canada drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 23 Europe drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 24 Europe discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 25 Europe development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 26 Europe drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 27 Europe drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 28 Germany drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 29 Germany discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 30 Germany development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 31 Germany drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 32 Germany drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 33 The U.K. drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 34 The U.K. discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 35 The U.K. development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 36 The U.K. drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 37 The U.K. drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 38 France drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 39 France discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 40 France development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 41 France drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 42 France drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 43 Italy drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 44 Italy discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 45 Italy development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 46 Italy drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 47 Italy drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 48 Spain drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 49 Spain discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 50 Spain development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 51 Spain drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 52 Spain drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 53 Asia Pacific drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 54Asia Pacific discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 55 Asia Pacific development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 56 Asia Pacific drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 57 Asia Pacific drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 58 Japan drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 59 Japan discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 60 Japan development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 61 Japan drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 62 Japan drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 63 China drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 64 China discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 65 China development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 66 China drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 67 China drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 68 India drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 69 India discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 70 India development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 71 India drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 72 India drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 73 Latin America drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 74 Latin America discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 75 Latin America development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 76 Latin America drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 77 Latin America drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 78 Brazil drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 79 Brazil discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 80 Brazil development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 81 Brazil drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 82 Brazil drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 83 Middle East & Africa drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 84 Middle East & Africa discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 85 Middle East & Africa development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 86 Middle East & Africa drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 87 Middle East & Africa drug discovery informatics market, by service, 2017 - 2028 (USD Million)
TABLE 88 South Africa drug discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 89 South Africa discovery informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 90 South Africa development informatics market, by workflow, 2017 - 2028 (USD Million)
TABLE 91 South Africa drug discovery informatics market, by mode, 2017 - 2028 (USD Million)
TABLE 92 South Africa drug discovery informatics market, by service, 2017 - 2028 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Drug discovery informatics market segmentation
FIG. 8 Global drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 9 Drug discovery informatics market dynamics
FIG. 10 Potential reasons for the failure of a candidate molecule
FIG. 11 Different cooperation models implemented for the outsourcing of informatic services
FIG. 12 Penetration & growth prospects mapping, for workflow, 2020
FIG. 13 Informatic service application in workflow segments, 2020
FIG. 14 Drug discovery informatics market Porter’s analysis
FIG. 15 Drug discovery informatics market PESTEL analysis
FIG. 16 Drug discovery informatics revenue share, by workflow, 2020 & 2025
FIG. 17 Discovery informatics market , 2017 - 2028 (USD Million)
FIG. 18 Identification, validation & assay development informatics market , 2017 - 2028 (USD Million)
FIG. 19 Lead generation informatics market , 2017 - 2028 (USD Million)
FIG. 20 Development informatics market, 2017 - 2028 (USD Million)
FIG. 21 Lead optimization market, 2017 - 2028 (USD Million)
FIG. 22 FHD preparation market, 2017 - 2028 (USD Million)
FIG. 23 Phase IA informatics market, 2017 - 2028 (USD Million)
FIG. 24 Phase IB/2 informatics market, 2017 - 2028 (USD Million)
FIG. 25 Drug discovery informatics revenue share, by mode, 2020 & 2025
FIG. 26 Outsourced informatics market , 2017 - 2028 (USD Million)
FIG. 27 In-house informatics market , 2017 - 2028 (USD Million)
FIG. 28 Drug discovery informatics revenue share, by service, 2020 & 2025
FIG. 29 Cost per raw Mega Base (Mb) of DNA sequence
FIG. 30 Cost per genome sequencing
FIG. 31 Sequence analysis platforms market , 2017 - 2028 (USD Million)
FIG. 32 Molecular modelling market , 2017 - 2028 (USD Million)
FIG. 33 Docking market , 2017 - 2028 (USD Million)
FIG. 34 Clinical trial data management market , 2017 - 2028 (USD Million)
FIG. 35 Other services market , 2017 - 2028 (USD Million)
FIG. 36 Global drug discovery informatics market share, by region, 2020 & 2025
FIG. 37 North America drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 38 The U.S. drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 39 Canada drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 40 Europe drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 41 Germany drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 42 The U.K. drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 43 France drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 44 Italy drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 45 Spain drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 46 Asia Pacific drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 47 Japan drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 48 China drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 49 India drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 50 Latin America drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 51 Brazil drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 52 Middle East & Africa drug discovery informatics market, 2017 - 2028 (USD Million)
FIG. 53 South Africa drug discovery informatics market, 2017 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の創薬インフォマティクス市場2021-2028:モード別(社内、アウトソーシング)、ワークフロー別(検出、開発)、サービス別(シーケンス分析プラットフォーム、ドッキング)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆